724 Fundamental Analysis - C3.AI INC-A

Fundamental Rating

Taking everything into account, 724 scores 4 out of 10 in our fundamental rating. 724 was compared to 125 industry peers in the Software industry. 724 has a great financial health rating, but its profitability evaluates not so good. 724 is quite expensive at the moment. It does show a decent growth rate.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year 724 has reported negative net income.
In the past year 724 has reported a negative cash flow from operations.
In the past 5 years 724 always reported negative net income.
In the past 5 years 724 always reported negative operating cash flow.

1.2 Ratios

724's Return On Assets of -39.67% is on the low side compared to the rest of the industry. 724 is outperformed by 90.40% of its industry peers.
Looking at the Return On Equity, with a value of -49.40%, 724 is doing worse than 84.00% of the companies in the same industry.

		Industry Rank	Sector Rank
ROA	-39.67%
ROE	-49.4%
ROIC	N/A

ROA(3y)-26.48%

ROA(5y)-20.1%

ROE(3y)-31.79%

ROE(5y)-24.01%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

The Gross Margin of 724 (51.76%) is worse than 70.40% of its industry peers.
In the last couple of years the Gross Margin of 724 has declined.
724 does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	51.76%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-6.75%

GM growth 5Y-4.23%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

724 does not have a ROIC to compare to the WACC, probably because it is not profitable.
724 has more shares outstanding than it did 1 year ago.
724 has more shares outstanding than it did 5 years ago.
724 has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

724 has an Altman-Z score of 3.55. This indicates that 724 is financially healthy and has little risk of bankruptcy at the moment.
724's Altman-Z score of 3.55 is in line compared to the rest of the industry. 724 outperforms 58.40% of its industry peers.
724 has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	N/A
Altman-Z	3.55

ROIC/WACCN/A

WACC10.99%

2.3 Liquidity

A Current Ratio of 6.47 indicates that 724 has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 6.47, 724 belongs to the top of the industry, outperforming 93.60% of the companies in the same industry.
724 has a Quick Ratio of 6.47. This indicates that 724 is financially healthy and has no problem in meeting its short term obligations.
Looking at the Quick ratio, with a value of 6.47, 724 belongs to the top of the industry, outperforming 93.60% of the companies in the same industry.

		Industry Rank	Sector Rank
Current Ratio	6.47
Quick Ratio	6.47

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

724 shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -157.14%.
724 shows a small growth in Revenue. In the last year, the Revenue has grown by 1.84%.
Measured over the past years, 724 shows a quite strong growth in Revenue. The Revenue has been growing by 19.95% on average per year.

EPS 1Y (TTM)-157.14%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-316.67%

Revenue 1Y (TTM)1.84%

Revenue growth 3Y15.45%

Revenue growth 5Y19.95%

Sales Q2Q%-20.34%

3.2 Future

The Earnings Per Share is expected to grow by 25.04% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 34.07% on average over the next years. This is a very strong growth

EPS Next Y-215.79%

EPS Next 2Y-57.87%

EPS Next 3Y-10.44%

EPS Next 5Y25.04%

Revenue Next Year-22.79%

Revenue Next 2Y-7.34%

Revenue Next 3Y3.86%

Revenue Next 5Y34.07%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for 724. In the last year negative earnings were reported.
Also next year 724 is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

A cheap valuation may be justified as 724's earnings are expected to decrease with -10.44% in the coming years.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y-57.87%

EPS Next 3Y-10.44%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

724 does not give a dividend.

		Industry Rank	Sector Rank
Dividend Yield	0%

More info and screens

Find the best dividend stocks

Show peers with best dividend

C3.AI INC-A

FRA:724 (1/16/2026, 7:00:00 PM)

11.636

-0.27 (-2.27%)

Chartmill FA Rating

GICS SectorInformation Technology

GICS IndustryGroupSoftware & Services

GICS IndustrySoftware

Earnings (Last)12-03 2025-12-03/amc

Earnings (Next)02-24 2026-02-24/amc

Inst Owners53.1%

Inst Owner ChangeN/A

Ins Owners24.52%

Ins Owner ChangeN/A

Market Cap1.60B

Revenue(TTM)352.91M

Net Income(TTM)-381.34M

Analysts50

Price Target14.6 (25.47%)

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	0%

Yearly DividendN/A

Dividend Growth(5Y)N/A

DP0%

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)1

Avg EPS beat(2)-28.17%

Min EPS beat(2)-82.01%

Max EPS beat(2)25.67%

EPS beat(4)3

Avg EPS beat(4)4.94%

Min EPS beat(4)-82.01%

Max EPS beat(4)53.41%

EPS beat(8)7

Avg EPS beat(8)33.35%

EPS beat(12)11

Avg EPS beat(12)37.21%

EPS beat(16)15

Avg EPS beat(16)39.65%

Revenue beat(2)0

Avg Revenue beat(2)-15.21%

Min Revenue beat(2)-27.87%

Max Revenue beat(2)-2.54%

Revenue beat(4)0

Avg Revenue beat(4)-8.67%

Min Revenue beat(4)-27.87%

Max Revenue beat(4)-2.02%

Revenue beat(8)1

Avg Revenue beat(8)-4.64%

Revenue beat(12)2

Avg Revenue beat(12)-3.67%

Revenue beat(16)3

Avg Revenue beat(16)-3.06%

PT rev (1m)-1.85%

PT rev (3m)-2.93%

EPS NQ rev (1m)-0.96%

EPS NQ rev (3m)0.36%

EPS NY rev (1m)3.99%

EPS NY rev (3m)3.99%

Revenue NQ rev (1m)0.55%

Revenue NQ rev (3m)0.36%

Revenue NY rev (1m)-0.53%

Revenue NY rev (3m)-0.53%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	5.28
P/FCF	N/A
P/OCF	N/A
P/B	2.42
P/tB	2.42
EV/EBITDA	N/A

EPS(TTM)-0.77

EYN/A

EPS(NY)-0.84

Fwd EYN/A

FCF(TTM)-0.58

FCFYN/A

OCF(TTM)-0.57

OCFYN/A

SpS2.2

BVpS4.82

TBVpS4.81

PEG (NY)N/A

PEG (5Y)N/A

Graham NumberN/A

Profitability

		Industry Rank	Sector Rank
ROA	-39.67%
ROE	-49.4%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	51.76%
FCFM	N/A

ROA(3y)-26.48%

ROA(5y)-20.1%

ROE(3y)-31.79%

ROE(5y)-24.01%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexgc growth 3YN/A

ROICexgc growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-6.75%

GM growth 5Y-4.23%

F-Score3

Asset Turnover0.37

Health

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	N/A
Debt/EBITDA	N/A
Cap/Depr	18.35%
Cap/Sales	0.69%
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	6.47
Quick Ratio	6.47
Altman-Z	3.55

F-Score3

WACC10.99%

ROIC/WACCN/A

Cap/Depr(3y)472.89%

Cap/Depr(5y)307.85%

Cap/Sales(3y)12.2%

Cap/Sales(5y)7.84%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)-157.14%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-316.67%

EPS Next Y-215.79%

EPS Next 2Y-57.87%

EPS Next 3Y-10.44%

EPS Next 5Y25.04%

Revenue 1Y (TTM)1.84%

Revenue growth 3Y15.45%

Revenue growth 5Y19.95%

Sales Q2Q%-20.34%

Revenue Next Year-22.79%

Revenue Next 2Y-7.34%

Revenue Next 3Y3.86%

Revenue Next 5Y34.07%

EBIT growth 1Y-32.22%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year-96.24%

EBIT Next 3Y-6.41%

EBIT Next 5YN/A

FCF growth 1Y21.93%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y-30.64%

OCF growth 3YN/A

OCF growth 5YN/A

C3.AI INC-A / 724.DE FAQ

What is the fundamental rating for 724 stock?

ChartMill assigns a fundamental rating of 4 / 10 to 724.DE.

What is the valuation status for 724 stock?

ChartMill assigns a valuation rating of 0 / 10 to C3.AI INC-A (724.DE). This can be considered as Overvalued.

How profitable is C3.AI INC-A (724.DE) stock?

C3.AI INC-A (724.DE) has a profitability rating of 0 / 10.

What is the financial health of C3.AI INC-A (724.DE) stock?

The financial health rating of C3.AI INC-A (724.DE) is 8 / 10.

Can you provide the expected EPS growth for 724 stock?

The Earnings per Share (EPS) of C3.AI INC-A (724.DE) is expected to decline by -215.79% in the next year.

C3.AI INC-A (724.DE) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens

C3.AI INC-A / 724.DE FAQ

What is the fundamental rating for 724 stock?

What is the valuation status for 724 stock?

How profitable is C3.AI INC-A (724.DE) stock?

What is the financial health of C3.AI INC-A (724.DE) stock?

Can you provide the expected EPS growth for 724 stock?